| The effects of mutant Ras proteins on the cell signalome T Takács, G Kudlik, A Kurilla, B Szeder, L Buday, V Vas Cancer and Metastasis Reviews 39, 1051-1065, 2020 | 48 | 2020 |
| Dynamic control of RSK complexes by phosphoswitch‐based regulation G Gógl, B Biri‐Kovács, ÁL Póti, H Vadászi, B Szeder, A Bodor, ... The FEBS journal 285 (1), 46-71, 2018 | 33 | 2018 |
| Enhanced in vitro antitumor activity of GnRH-III-daunorubicin bioconjugates influenced by sequence modification S Schuster, B Biri-Kovács, B Szeder, L Buday, J Gardi, Z Szabó, ... Pharmaceutics 10 (4), 223, 2018 | 26 | 2018 |
| Advances in understanding TKS4 and TKS5: Molecular scaffolds regulating cellular processes from podosome and invadopodium formation to differentiation and tissue homeostasis G Kudlik, T Takács, L Radnai, A Kurilla, B Szeder, K Koprivanacz, ... International Journal of Molecular Sciences 21 (21), 8117, 2020 | 24 | 2020 |
| Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery S Schuster, B Biri-Kovács, B Szeder, V Farkas, L Buday, Z Szabó, ... Beilstein Journal of Organic Chemistry 14 (1), 756-771, 2018 | 24 | 2018 |
| The scaffold protein Tks4 is required for the differentiation of mesenchymal stromal cells (MSCs) into adipogenic and osteogenic lineages M Dülk, G Kudlik, A Fekete, D Ernszt, K Kvell, JE Pongrácz, BL Merő, ... Scientific reports 6 (1), 34280, 2016 | 24 | 2016 |
| Cellular internalization and inhibition capacity of new anti-glioma peptide conjugates: physicochemical characterization and evaluation on various monolayer-and 3D-spheroid … Z Baranyai, B Biri-Kovács, M Kratky, B Szeder, ML Debreczeni, J Budai, ... Journal of medicinal chemistry 64 (6), 2982-3005, 2021 | 23 | 2021 |
| In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery AAP Tripodi, I Ranđelović, B Biri-Kovács, B Szeder, G Mező, J Tóvári Pathology & Oncology Research 26, 1879-1892, 2020 | 23 | 2020 |
| EGF regulates the interaction of Tks4 with Src through its SH2 and SH3 domains M Dülk, B Szeder, G Glatz, BL Merő, K Koprivanacz, G Kudlik, V Vas, ... Biochemistry 57 (28), 4186-4196, 2018 | 22 | 2018 |
| Structural insights into the tyrosine phosphorylation–mediated inhibition of SH3 domain–ligand interactions B Merő, L Radnai, G Gógl, O Tőke, I Leveles, K Koprivanacz, B Szeder, ... Journal of Biological Chemistry 294 (12), 4608-4620, 2019 | 16 | 2019 |
| Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line L Hámori, G Kudlik, K Szebényi, N Kucsma, B Szeder, Á Póti, F Uher, ... International Journal of Molecular Sciences 21 (4), 1185, 2020 | 15 | 2020 |
| Structure–activity relationship of HER2 receptor targeting peptide and its derivatives in targeted tumor therapy B Biri-Kovács, A Adorján, I Szabó, B Szeder, S Bősze, G Mező Biomolecules 10 (2), 183, 2020 | 15 | 2020 |
| Significance of the Tks4 scaffold protein in bone tissue homeostasis V Vas, T Kovács, S Körmendi, A Bródy, G Kudlik, B Szeder, D Mező, ... Scientific Reports 9 (1), 5781, 2019 | 15 | 2019 |
| Absence of the Tks4 scaffold protein induces epithelial-mesenchymal transition-like changes in human colon cancer cells B Szeder, J Tárnoki-Zách, D Lakatos, V Vas, G Kudlik, B Merő, ... Cells 8 (11), 1343, 2019 | 13 | 2019 |
| Analysis of Tks4 knockout mice suggests a role for Tks4 in adipose tissue homeostasis in the context of beigeing V Vas, T Háhner, G Kudlik, D Ernszt, K Kvell, D Kuti, KJ Kovács, J Tóvári, ... Cells 8 (8), 831, 2019 | 12 | 2019 |
| Disordered regions of mixed lineage leukemia 4 (MLL4) protein are capable of RNA binding B Szabó, N Murvai, R Abukhairan, É Schád, J Kardos, B Szeder, L Buday, ... International Journal of Molecular Sciences 19 (11), 3478, 2018 | 12 | 2018 |
| Comparison of complexes formed by a crustacean and a vertebrate trypsin with bovine pancreatic trypsin inhibitor–the key to achieving extreme stability? T Molnár, J Vörös, B Szeder, K Takáts, J Kardos, G Katona, L Gráf The FEBS Journal 280 (22), 5750-5763, 2013 | 12 | 2013 |
| Old polyanionic drug suramin suppresses detrimental cytotoxicity of the host defense peptide LL-37 M Quemé-Peña, M Ricci, T Juhász, K Horváti, S Bősze, B Biri-Kovács, ... ACS Pharmacology & Translational Science 4 (1), 155-167, 2020 | 9 | 2020 |
| Modification of Short Non‐Permeable Peptides to Increase Cellular Uptake and Cytostatic Activity of Their Conjugates M Yousef, I Szabó, B Biri‐Kovács, B Szeder, F Illien, S Sagan, Z Bánóczi ChemistrySelect 6 (38), 10111-10120, 2021 | 7 | 2021 |
| A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides K Horvati, B Pályi, J Henczko, G Balka, E Szabo, V Farkas, B Biri-Kovacs, ... Vaccines 7 (3), 101, 2019 | 7 | 2019 |
